INDIAN BENCHMARKS are likely to open on a cautious note as the global cues look mixed with SGX Nifty trading 12.50 points lower.
Headlines for the day:
Aurobindo Pharma receives USFDA approval for anti-epileptic drug.
Biocon's arm Syngene International gets SEBI approval for IPO.
TVS Srichakra extends gain on ties up with France's Michelin.
Trend in FII flows: The FIIs were net sellers of Rs -604.86 Cr in the cash segment on Monday while the DIIs were net buyers of Rs 650.47 Cr, as per the provisional figures released by the NSE.
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. CapitalStras On you Tube & also ave liable on linke din and facebook. Get real time advice for Share Tips , Trading Strategies , Best Intraday Stocks , Stock Tips Free NSE Stock Market Tips and all market updates. For 2 Days Free Trial ,Please visit our site http://www.capitalstars.com Call at 0731-6790000, 6669900.
0 comments:
Post a Comment